• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,264.33 736.38
( 0.97%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
69,318.21 3,298.17
(5.00%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.6032787
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
37.3
71.68
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

FDC consolidated net profit rises 167.39% in the March 2026 quarter
May 27,2026
Net profit of FDC rose 167.39% to Rs 103.40 crore in the quarter ended March 2026 as against Rs 38.67 crore during the previous quarter ended March 2025. Sales rose 18.89% to Rs 584.79 crore in the quarter ended March 2026 as against Rs 491.89 crore during the previous quarter ended March 2025.

For the full year,net profit rose 5.48% to Rs 281.42 crore in the year ended March 2026 as against Rs 266.79 crore during the previous year ended March 2025. Sales rose 2.98% to Rs 2170.93 crore in the year ended March 2026 as against Rs 2108.12 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales584.79491.89 19 2170.932108.12 3
OPM %18.1910.97 -15.9415.41 -
PBDT154.7068.87 125 454.63410.95 11
PBT140.3553.31 163 395.39357.22 11
NP103.4038.67 167 281.42266.79 5